OptimizeRx Corp (OPRX) Cost of Revenue USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
OptimizeRx Corp quarterly/annual Cost of Revenue history and growth rate from 2013 to 2024.
  • OptimizeRx Corp Cost of Revenue for the quarter ending March 31, 2024 was $7.49 M, a 34.4% increase year-over-year.
  • OptimizeRx Corp Cost of Revenue for the twelve months ending March 31, 2024 was $30.5 M, a 30.4% increase year-over-year.
  • OptimizeRx Corp annual Cost of Revenue for 2023 was $28.6 M, a 21.9% increase from 2022.
  • OptimizeRx Corp annual Cost of Revenue for 2022 was $23.5 M, a 8.46% decline from 2021.
  • OptimizeRx Corp annual Cost of Revenue for 2021 was $25.7 M, a 33.6% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $30.5 M $7.49 M +$1.92 M +34.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $28.6 M $10.5 M +$3.33 M +46.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 $25.3 M $6.53 M +$866 K +15.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $24.4 M $5.99 M +$1 M +20.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $23.4 M $5.57 M -$59.9 K -1.06% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $23.5 M $7.2 M -$721 K -9.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 $24.2 M $5.66 M -$1.38 M -19.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $25.6 M $4.99 M -$592 K -10.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $26.2 M $5.63 M +$525 K +10.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $25.7 M $7.92 M +$98.7 K +1.26% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $25.6 M $7.05 M +$2.54 M +56.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $23 M $5.58 M +$1.94 M +53.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $21.1 M $5.1 M +$1.86 M +57.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $19.2 M $7.82 M +$4.92 M +169% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
Q3 2020 $14.3 M $4.5 M +$2.52 M +127% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $11.8 M $3.64 M +$952 K +35.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $10.8 M $3.24 M +$1.66 M +105% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $9.16 M $2.91 M +$421 K +16.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 $8.74 M $1.98 M -$288 K -12.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $9.03 M $2.69 M +$450 K +20.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $8.58 M $1.58 M -$425 K -21.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $9 M $2.49 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $2.27 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $2.24 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $2.01 M +$626 K +45.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $1.38 M +$489 K +54.8% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-03
Q1 2016 $893 K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q3 2014 $859 K +$330 K +62.3% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q3 2013 $529 K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.